Metabolic engineering of plant alkaloid biosynthesis
AUTOR(ES)
Sato, Fumihiko
FONTE
The National Academy of Sciences
RESUMO
Plant alkaloids, one of the largest groups of natural products, provide many pharmacologically active compounds. Several genes in the biosynthetic pathways for scopolamine, nicotine, and berberine have been cloned, making the metabolic engineering of these alkaloids possible. Expression of two branching-point enzymes was engineered: putrescine N-methyltransferase (PMT) in transgenic plants of Atropa belladonna and Nicotiana sylvestris and (S)-scoulerine 9-O-methyltransferase (SMT) in cultured cells of Coptis japonica and Eschscholzia californica. Overexpression of PMT increased the nicotine content in N. sylvestris, whereas suppression of endogenous PMT activity severely decreased the nicotine content and induced abnormal morphologies. Ectopic expression of SMT caused the accumulation of benzylisoquinoline alkaloids in E. californica. The prospects and limitations of engineering plant alkaloid metabolism are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14596Documentos Relacionados
- Alkaloid Biosynthesis[mdash]The Basis for Metabolic Engineering of Medicinal Plants.
- Progress in plant metabolic engineering
- Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition.
- Metabolic Engineering of Isoflavonoid Biosynthesis in Alfalfa1[w]
- Metabolic pathway engineering in cotton: Biosynthesis of polyhydroxybutyrate in fiber cells
